StockRing.com   Home    DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH   
  iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   
 4/24/2014, (NASDAQ:SLXP), $110.78 +0.83, +0.75%, "HOLD" Salix Pharmaceuti Stock
 




  
  

SLXP rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

On   4/24/2014   StockRing.com recommends to   "HOLD"   SLXP   stock at current price of   $110.78.
Today SLXP stock opened at $110.84 and was trading in the daily range of $ 106.23 - 111.248 per share.
Salix Pharmaceuti (NASDAQ:SLXP) Market capitalization is $7.016B. SLXP average daily volume is 1,098,130.
On last trading session SLXP stock traded 902,396 shares. Also the Short Ratio for (NASDAQ:SLXP) stock is 5.70.
Last year Salix Pharmaceuti(NASDAQ:SLXP) before taxes (EBITDA) (ttm) earned $316.3M on revenue of $933.8M.
SLXP 50-Day Moving Average is $106.35 vs. $110.78 now and 200-Day Moving Average is $92.83 vs. $110.78.
--------------------------------------------------------------------------------------------------------------------
VIX is "HOLD".  Nasdaq is "BUY".  S&P 500 is "BUY" on  4/17/2014
--------------------------------------------------------------------------------------------------------------------
SLXP Earnings Per Share - EPS (ttm) is 2.18. SLXP Stock Price Per Earnings ratio - P/E is 50.44.
Salix Pharmaceuti(NASDAQ:SLXP) stock pays a dividend of $0.00 per share which is a yield of N/A%.
On average analysts predict that One Year Target Estimated price for SLXP stock is $119.73.
In the last 52 weeks SLXP stock was trading in the range of $49.78 - 120.00.
 
 
  Our FREE iPhone App Buy-Sell-Hold ratings for 4573 stocks & ETFs:
 
1. DOW30+    Part 1    199 Stocks    Updated: 4/17/2014 1:36:28 AM
2. DOW30+    Part 2    192 Stocks    Updated: 4/17/2014 1:50:47 AM
3. DOW30+    Part 3    193 Stocks    Updated: 4/17/2014 1:55:09 AM
4. DOW30+    Part 4    195 Stocks    Updated: 4/17/2014 1:59:27 AM
 
5. ENERGY    Part 1    188 Stocks    Updated: 4/18/2014 10:46:27 AM
6. ENERGY    Part 2    186 Stocks    Updated: 4/18/2014 10:51:32 AM
7. ENERGY    Part 3    196 Stocks    Updated: 4/18/2014 10:56:58 AM
 
8. HEALTH    Part 1    184 Stocks    Updated: 4/16/2014 2:02:40 AM
9. HEALTH    Part 2    138 Stocks    Updated: 4/16/2014 2:07:27 AM
 
10. FINANCE    Part 1    191 Stocks    Updated: 11/13/2013 10:58:43 AM
11. FINANCE    Part 2    193 Stocks    Updated: 11/13/2013 12:29:31 PM
12. FINANCE    Part 3    188 Stocks    Updated: 11/13/2013 12:42:47 PM
13. FINANCE    Part 4    188 Stocks    Updated: 11/13/2013 12:46:35 PM
14. FINANCE    Part 5    190 Stocks    Updated: 11/13/2013 10:52:57 AM
 
15. SERVICE    Part 1    181 Stocks    Updated:  TODAY , 4/24/2014 1:06:54 AM
16. SERVICE    Part 2    186 Stocks    Updated:  TODAY , 4/24/2014 1:11:49 AM
17. SERVICE    Part 3    183 Stocks    Updated:  TODAY , 4/24/2014 1:19:16 AM
18. SERVICE    Part 4    193 Stocks    Updated:  TODAY , 4/24/2014 1:33:13 AM
 
19. TECH    Part 1    187 Stocks    Updated: 4/17/2014 11:25:01 PM
20. TECH    Part 2    183 Stocks    Updated: 4/17/2014 11:29:45 PM
21. TECH    Part 3    185 Stocks    Updated: 4/17/2014 11:34:24 PM
22. TECH    Part 4    102 Stocks    Updated: 4/17/2014 11:37:10 PM
 
23. IPOs    200 Stocks    Updated: 4/18/2014 7:17:48 PM
 
24. ETFs    Part 1    193 Stocks    Updated: 4/21/2014 5:56:28 PM
25. ETFs    Part 2    191 Stocks    Updated: 4/21/2014 6:05:32 PM
26. ETFs    Part 3    157 Stocks    Updated: 4/22/2014 2:46:24 AM

BUY  DOW 30+:    ENERGY: CDW  CBA  TSRE  QIWI  EIGI     HEALTH: IEZ  EPHE  FM  JKF  IEO 
      FINANCE: XLK  DWX  GII  SRLN  SLY     SERVICES: TQQQ  MLPX  GLL  DDM  CNPF     TECH: CSGP  WDC  ONNN  RENN  JNPR 
SELL  DOW 30+: GGB     ENERGY: MKTO  Q  HASI  SRLP  TSC     HEALTH: EMFN  MUAC  ISHG  GNMA  SLVP 
      FINANCE: GOVT  SLQD  PGM  JJU  XVZ     SERVICES: UST  YCL  SRTY  MYY  UVXY     TECH: BRKR  CPHD  IPGP  LLTC  MDRX 


Samples of StockRing Real Time "Buy-Sell-Hold" stock Ratings:



  Enter Stock:  
  
    
    
 
 



Download StockRing Free  Buy-Sell-Hold iPhone
App for 1,200 stocks in Energy Healthcare Finance Services & Tech


DOW 30+

ENERGY

HEALTH

FINANCE

SERVICES

TECH

BUY  DOW 30+:    ENERGY: WPT  WBB  VOYA  VMEM  TSRE     HEALTH: WOOD  TZW  TZV  TZE  TZD 
      FINANCE: XTN  XTL  XSW  XSD  XPH     SERVICES: ZSL  YCS  UYM  UWM  UWC     TECH: WDC  SWIR  RENN  ONNN  NTAP 
SELL  DOW 30+: GGB     ENERGY: XON  XGTI  UBIC  TSC  TNDM     HEALTH: TLH  SLVP  SHV  RING  MUAE 
      FINANCE: XVZ  VXZ  VXX  SLQD  SIL     SERVICES: YCL  VIXY  UVXY  UST  ULE     TECH: YNDX  XRX  XLNX  WIT  WCC 

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

Our FREE iPhone App with Buy-Sell-Hold ratings for 4,030 stocks:

  iPhone App Buy-Sell-Hold Ratings for 5-5-2013
           
           
           
           
     
  

 
  Enter Stock:  
  
    
    
 



4/24/2014  Thursday, April 24, 2014 (Irvine, California) Today StockRing.com Recommendation is to "HOLD"for Salix Pharmaceuti (NASDAQ:SLXP) Stock. SLXP stock opening price was $110.84 per share. Current price of NASDAQ:SLXP Stock is $110.78 per share and it is $+0.83, (+0.75%) today and it was trading in the daily range of $106.23 - 111.248 per share. Current Bid Price for (NASDAQ:SLXP) stock is $110.75 and the Ask Price is $115.87. In the last 52 weeks SLXP stock was trading in the range of $49.78 - 120.00. 50-Day Moving Average for (NASDAQ:SLXP) stock is $106.35 and 200-Day Moving Average is $92.83. On average analysts predict that One Year Target Estimated price for (NASDAQ:SLXP) stock is $119.73.

Salix Pharmaceuti (NASDAQ:SLXP) is rated as a wait on 4/16/2014 2:17:23 AM.

Salix Pharmaceuti (NASDAQ:SLXP) Market capitalization is $7.016B. (NASDAQ:SLXP) stock average daily volume is 1,098,130 shares per day. However, on last trading session of Apr 24, 2012 SLXP stock traded 902,396 shares. Also The Number of days it would take short sellers on average to repurchase all the borrowed shares or Short Ratio for (NASDAQ:SLXP) stock is 5.70. On previous trading session SLXP Stock closed at $109.95 per share.

Last year Salix Pharmaceuti (NASDAQ:SLXP) before taxes (EBITDA) (ttm) earned $316.3M on total revenue of $933.8M. Earnings Per Share - EPS (ttm) for SLXP stock is 2.18. Also, (NASDAQ:SLXP) Stock Price Per Earnings ratio - P/E is 50.44. Thus, (NASDAQ:SLXP) Stock Price/Sales (ttm) ratio is 7.46 and Price/Book (mrq) ratio is 9.34.

(NASDAQ:SLXP) Stock does NOT PAY any dividend. So at this time (NASDAQ:SLXP) Stock maintains Trailing Annual Dividend Rate at 0.00 .


StockRing Recommendations for Salix Pharmaceuti (NASDAQ:SLXP) Stock are updated daily here

http://StockRing.com/sr/Buy-Sell-Hold-Stock-Analysis-Ratings.asp?StockName=SLXP

At this time StockRing recommends to buy LONG positions on many stocks from Dow 30+ stocks that currently have a BUY or SUPER BUY rating. If you decide to take a SHORT position and actually sell some stocks sjort right now - please check the section of Dow 30+ stocks that have a SELL or SUPER SELL rating.

If you would like to receive Buy-Sell-Hold ratings for stocks from Energy, Healthcare, Finance, Services & Hi-Tech sectors on your iPhone, then please download Buy-Sell-Hold iPhone App here:


Free Limited or $10 Full Version  Buy-Sell-Hold iPhone App
for 1,200 stocks in Energy, Healthcare, Finance, Services and Tech


DOW 30+

ENERGY

HEALTH

FINANCE

SERVICES

TECH


 
  Enter Stock:  
  
    
    
 
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

NASDAQ:SLXP Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max    Options   More Info

SLXP rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

4/24/2014 1 Year Stock market price chart for Salix Pharmaceuti (NASDAQ:SLXP) Stock on Thursday, April 24, 2014
  
1 Year SLXP 1 Year Dow Jones
1 Year Nasdaq 1 Year S&P 500
4/24/2014 5 days Stock market price chart for Salix Pharmaceuti (NASDAQ:SLXP) Stock on Thursday, April 24, 2014
  
5 Days SLXP 5 Days Dow Jones
5 Days Nasdaq 5 Days S&P 500
  

EUROs for $1 DOLLAR: 30 days
     

NASDAQ:SLXP Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max    Options   More Info
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

SLXP rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

4/24/2014 Stock market price quote data for Salix Pharmaceuti (NASDAQ:SLXP) Stock on Thursday, April 24, 2014

Last Trade: 110.78
Trade Time: Apr 24
Change: +0.83, (+0.75%)
Prev Close: 109.95
Open: 110.84
Bid: 110.75
Ask: 115.87
1y Target Est: $119.73
50-Day Moving Average: 106.35
200-Day Moving Average:
92.83
Short Ratio: 5.70
Trailing Annual Dividend Rate: 0.00
Day's Range: 106.23 - 111.248
52wk Range: 49.78 - 120.00
Volume: 902,396
Avg Vol: 1,098,130
Market Cap: 7.016B
P/E (ttm): 50.44
EPS (ttm): 2.18
Div & Yield: 0.00 (N/A%)
Revenue (ttm): 933.8M
Earnings before Tax (EBITDA) (ttm): 316.3M
Price/Sales (ttm): 7.46
Price/Book (mrq): 9.34
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

  
  
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

SLXP rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs



4/24/2014 Latest stock market news data for Salix Pharmaceuti (NASDAQ:SLXP) Stock on Thursday, April 24, 2014

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

SLXP rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

Salix Pharmaceuticals Ltd.: Salix Pharmaceuticals Announces 1Q2014 Financial ...
The Wall Street Transcript - 10 hours ago
RALEIGH, NC, April 24, 2014 - Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will report first quarter 2014 financial results following the close of the U.S.
Salix Pharmaceuticals, Progenics Pharmaceuticals Announce the Acceptance of ...
Benzinga - Apr 22, 2014
Salix Pharmaceuticals, Ltd. (Nasdaq: SLXP) and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) announced today that the submission to the European Medicines Agency (EMA) of RELISTOR®(methylnaltrexone bromide) Subcutaneous Injection for the ...
Salix Pharmaceuticals Now Covered by Analysts at Sterne Agee (SLXP)
WKRB News - Apr 17, 2014
Salix Pharmaceuticals, Ltd. logo Sterne Agee began coverage on shares of Salix Pharmaceuticals (NASDAQ:SLXP) in a research note issued to investors on Wednesday, TheFlyOnTheWall.
Stocks Buzz- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP), ZyngaInc (NASDAQ ... - Techsonian (press release)
Salix Pharmaceuticals Receives Average Recommendation of “Hold” from ...
WKRB News - Apr 14, 2014
Salix Pharmaceuticals, Ltd. is a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs and medical devices used in the treatment of a variety of gastrointestinal disorders, which are those affecting ...
Salix Pharmaceuticals Coverage Initiated at Jefferies Group (SLXP)
Zolmax - Apr 23, 2014
Salix Pharmaceuticals, Ltd. logo Equities researchers at Jefferies Group assumed coverage on shares of Salix Pharmaceuticals (NASDAQ:SLXP) in a research report issued on Monday, TheFlyOnTheWall.
Declarations in Focus: Salix Pharmaceuticals (NASDAQ:SLXP), Magnum Hunter ...
eMarketsDaily - Apr 23, 2014
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) [Trend Analysis] and Progenics Pharma (PGNX) reported that that the submission to the European Medicines Agency of RELISTOR (methylnaltrexone bromide) Subcutaneous Injection for the treatment of ...
Why Salix Pharmaceuticals (SLXP) Could Be a Potential Winner
Zacks.com - Mar 26, 2014
One such company that looks well positioned for a solid gain, but has been overlooked by investors lately, is Salix Pharmaceuticals Ltd. (SLXP - Analyst Report). This specialty pharmaceutical company has actually seen estimates rise over the past month ...
Active Movers – Hercules Offshore, (NASDAQ:HERO), AutoNation, Inc. (NYSE ... - Techsonian (press release)
Salix Pharmaceuticals Coverage Initiated by Analysts at Sterne Agee (SLXP)
Mideast Time - Apr 18, 2014
Salix Pharmaceuticals, Ltd. logo Research analysts at Sterne Agee began coverage on shares of Salix Pharmaceuticals (NASDAQ:SLXP) in a report released on Wednesday, TheFlyOnTheWall.
Notable Movers: Salix Pharmaceuticals, Ltd. (SLXP), Level 3 Communications ...
Techsonian (press release) - Mar 28, 2014
Las Vegas, NV - March 28, 2014 - (TechSonian) –Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) announced that the Company presented at the 26th Annual ROTH Conference in Laguna Niguel, CA on Tuesday, March 11, 2014 at 1:30 p.m.
Stock's Buzzers- Salix Pharmaceuticals, Ltd. (SLXP), North American Palladium ...
Techsonian (press release) - Apr 4, 2014
... revenue surged 30% to $257.6 million. Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) decreased -3.20% and closed at $104.99 in the last trading session with the overall traded volume of 1.67 million shares, versus the average volume of 1.19 million shares.

 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   


Hottest Healthcare Stocks Now – NBIX SLXP ALNY WMGI
Investorplace.com
Salix Pharmaceuticals (SLXP): SLXP stock is up 3.8%, marking the fourth consecutive day the stock has increased. Alnylam Pharmaceuticals (ALNY): ALNY stock is up 3.5% today. Wright Medical Group (WMGI): WMGI stock is up 3.2%, marking the third ...


Analysts: Salix is one of the most undervalued pharmas
Triangle Business Journal (blog)
... Pharmaceuticals (Nasdaq: SLXP) as “heavily skewed to the upside” in front of new data the company will soon release on Xifaxan, its leading drug, and sees the company as a “strong candidate to participate in the ongoing consolidation across the ...
Salix Pharmaceuticals Now Covered by Analysts at Sterne Agee (SLXP)WKRB News
Stocks Buzz- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP), ZyngaInc (NASDAQ ...Techsonian (press release)

all 3 news articles »

Biggest Movers in Healthcare Stocks Now – QCOR AGN IDXX WCG
Investorplace.com
Salix Pharmaceuticals (SLXP): SLXP stock is up 0.8%, marking the sixth consecutive day the stock has increased. Myriad Genetics (MYGN): MYGN stock is up 0.7%, marking the third consecutive day the stock has increased. Fresenius Medical Care Corp ...


Salix Pharmaceuticals Coverage Initiated at Jefferies Group (SLXP)
Mideast Time
Jefferies Group started coverage on shares of Salix Pharmaceuticals (NASDAQ:SLXP) in a research report sent to investors on Monday morning, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $133.00 price target on the stock.


Biggest Movers in Healthcare Stocks Now – AGN CNC NKTR VRX
Investorplace.com
Salix Pharmaceuticals (SLXP): SLXP stock is up 4.5%, marking the fifth consecutive day the stock has increased. Glaxosmithkline Plc (GSK): GSK stock is up 4.5% today. Shire Plc American Depositary Shares (SHPG): SHPG stock is up 4.0%, marking the ...


Dr. Reddys Launches Generic Antara
Zacks.com
Others stocks that look attractive include Salix Pharmaceuticals Ltd. (SLXP - Analyst Report), Impax Laboratories Inc. (IPXL - Snapshot Report) and Enanta Pharmaceuticals, Inc. (ENTA - Snapshot Report). Salix Pharma and Enanta carry a Zacks Rank #1 ...


Can Endo's CEO Do An Encore Of His Playbook At Valeant? Guru Funds Think So.
Seeking Alpha
Shares of Endo International are down huge in this correction, paralleling moves in many biotech stocks, but unlike the smaller corrections in many of its generic and specialty pharmaceutical peers. ... In the absence of company-specific news, we would ...

and more »

Why Salix Pharmaceuticals (SLXP) Could Be a Potential Winner
Zacks.com
So if you are looking for a stock flying under-the-radar that is well-equipped to bounce down the road, make sure to consider Salix Pharma. Solid estimate revisions and an impressive Zacks Rank suggest that better days may be ahead for SLXP and that ...
Active Movers – Hercules Offshore, (NASDAQ:HERO), AutoNation, Inc. (NYSE ...Techsonian (press release)

all 2 news articles »

Salix Pharmaceuticals Coverage Initiated by Analysts at Sterne Agee (SLXP)
Mideast Time
Research analysts at Sterne Agee began coverage on shares of Salix Pharmaceuticals (NASDAQ:SLXP) in a report released on Wednesday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $126.00 price target on the stock. Sterne Agee's ...


Valeant's Bid For Allergan Boosts Ethical Drug Stocks AGN VRX
Investor's Business Daily
Salix Pharmaceuticals (SLXP) rose 4% for its fifth straight gain. The stock has retaken its 10-week moving average as it works on the right side of a late-stage base. Profit at the maker of drugs to treat gastrointestinal ailments rose 31% last quarter ...

and more »

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

SLXP rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs


4/24/2014 News from StockRing Blog about Salix Pharmaceuti (NASDAQ:SLXP) Stock on Thursday, April 24, 2014



Copyright © 2012 StockRing.com. All rights reserved.
Subscriber Agreement   Privacy Agreement   Stocks   MutualFunds

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither StockRing.com nor its partners shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the StockRing site, a user agrees not to redistribute the information found therein.